• PDF: Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

Contraceptives
Technologies and Global Markets

  • Publication Date:June 2010
  • Publisher:BCC Research
  • Product Type: Report
  • Pages:146

Contraceptives Technologies and Global Markets

This Report Contains

  • Breakdown of The Global Market by Type, Specifically Barrier Methods, Such as Condoms, Spermicides, Diaphragms, Cervical Caps, and Contraceptive Sponges; and Hormonal Methods, Such as Birth-Control Pills and Patches, Depo-Provera, Vaginal Rings, and Intrauterine Devices (Iuds)
  • Analysis of Market Trends, with Data for 2008 and 2009, Estimates for 2010, and Projections of Compound Annual Growth Rates (Cagrs) through 2015
  • Overview of The Efficacy for Each Birth-Control Measure and The Risks Involved
  • Geographic Breakdown of Demand and Production, Economic Trends, and Social Influences
  • Comprehensive Company Profiles and Patent Analyses.

Introduction

Study Objectives

BCC' S Goal in Conducting This Study Is to Provide An Overview of The Current and Future Characteristics of The Global Market for Contraceptive Products and Technologies in Today' S World. The Key Objective Is to Present A Comprehensive Analysis of The Current Contraceptive Market and Its Future Direction as An Important Method for Control over Child Birth - and Hence The Population - and Also as A Method of Protection from Sexually Transmitted Diseases.

This Report Explores Present and Future Strategies within The Contraceptive Industry, Including The Prevalence and Market Trends of The Products Used. The Improvisation of The Market, The Setbacks, and The Needs of The Market Are Discussed, as Well as Various Types of Contraceptive Methods, Their Usage and Efficacy, and The Technologies Used in The past and Present.

A Detailed Analysis of The Contraceptive Industry Structure Has Been Conducted, Which Includes The Manufacturing of Various Types of Contraceptives. Revenues Are Broken down by Region. Sales Figures Are Estimated for The 5 - Year Period from 2010 through 2015.

Prevalence of Contraceptive Methods Are Also Discussed Separately in The Report, with An Explanation of The Decreased Use in Some Countries. The Report Also Covers Significant Patents and Their Allotments in Each Category.

Reasons for Doing This Study

This Study Was Conducted to Provide An Update of New Developments in The Market of Contraception Technology and to Provide Detailed Market Analysis of Contraceptive Products along with The Factors Affecting This Market. This Industry Was Influenced by The Economic Downturn, but unlike Other Industries IT Was Affected in A Positive Way. The Advancements and The Need for Better and Safer Contraception Methods Have Always Influenced Market Growth. This Study Analyzes Almost All The Systems Affected by These Factors.

Acquisition Strategies and Collaborations by Companies Are Covered in This Report, as Well as The Strength and Weaknesses of Each Type of Contraception Method in Light of New Technologies, Growing Competition, and Changing Customer Needs.

Intended Audience

This Study Contributes to The Areas of Market Growth in Contraception through Contraceptive Products and Technologies from The Point of View of Manufacturers and Users. Analytical Companies, Physicians, The Pharmaceutical and Biopharmaceutical Industries, Hospitals and Research Institutes Will Find This Study to Be of Interest.

Scope of Report

The Scope of This Study Encompasses The Contraception Markets. BCC Analyzes Each Market by Its Prevalence, Method of Usage, Regulatory Environment, Technology, Market Projections, and Market Share. Technological Issues Include The Latest Trends and Developments. The Study Also Includes Women at Risk and Other Factors Influencing The Market.

Methodology

Both Primary and Secondary Research Methodologies Were Used in This Study. BCC Conducted A Comprehensive Literature Search, Which Included Technical Newsletters and Journals, and Many Other Sources. Data Was Collected through Online Research and Correspondence with Various Analytical/Chemical/Pharmaceutical/Biotechnical Experts.

Information Sources

Many Companies within The Industry Were Surveyed to Obtain Data for This Study. Included Were Manufacturers and Suppliers of Contraceptives. Data Was Gathered from Various Industry Sources. BCC Consulted and Surveyed All The Possible Resources within The Industry, Consulted Newsletters, Company Literature, Product Literature, and A Host of Technical Articles, Journals, Indexes, and Abstracts. Exhaustive Investigations of Databases by Key Terminology Were Completed. in Addition, Data Was Compiled from Current Financial, Trade, and Government Sources.

  • Chapter- 1: Introduction -- Complimentary
    • Study Objectives
    • Reasons for Doing This Study
    • Intended Audience
    • Scope of Report
    • Methodology
    • Information Sources
    • about The Author
    • Related BCC Research Reports
    • BCC Online Services
    • Disclaimer
  • Chapter-2: Executive Summary
    • Executive Summary
    • Summary Table Worldwide Revenue of Contraceptive Market, through 2015 ($ Millions)
    • Summary Figure Worldwide Revenue of Contraceptive Market, 2008-2015 ($ Millions)
  • Chapter-3: Overview
    • Updates from The Fda
    • Labeling for Ortho Evra Contraceptive Patch
    • Fda Warnings for Nonoxynol 9 Otc Contraceptive Products
    • New Drug Application
    • Approvals of Contraceptive Products
    • Table 20 New Device Approvals in Contraception, 2006-2009
    • Table 21 Regulatory Chnages and Approvals in Contraception, 2006 - 2009
    • Other Approvals
    • The Fda Approval of Adiana Permanent Contraception
    • The European Medicines Agency Marketing Approval for Ellaone
    • Family Health International Seeks Approval of Chinese Contraceptive in Africa
    • Table 22 Safety Alerts, 2006-2009
  • Chapter-4: Regulatory Aspects
    • Updates from The Fda
    • Labeling for Ortho Evra Contraceptive Patch
    • Fda Warnings for Nonoxynol 9 Otc Contraceptive Products
    • New Drug Application
    • Approvals of Contraceptive Products
    • Table 20 New Device Approvals in Contraception, 2006-2009
    • Table 21 Regulatory Chnages and Approvals in Contraception, 2006 - 2009
    • Other Approvals
    • The Fda Approval of Adiana Permanent Contraception
    • The European Medicines Agency Marketing Approval for Ellaone
    • Family Health International Seeks Approval of Chinese Contraceptive in Africa
    • Table 22 Safety Alerts, 2006-2009
    • Table 22 (Continued) 37
  • Chapter-5: Prevalance of Contraceptives
    • Contraceptive Prevalence Rate
    • Table 23 Worldwide Prevalence of Contraceptives (%)
    • Influences behind A Slackened Pace
    • Limited Method Mix
    • Sheer Growth in Numbers
    • Changing Demographic Profile within The Reproductive Years
    • Proximate Determinants 41
  • Chapter-6: Industry Structure
    • Market Leaders in The Contraceptive Industry
    • Hormonal Oral Contraceptives
    • Table 24 Leading Manufacturers/Suppliers of Hormonal Oral Contraceptives
    • Hormonal Contraceptive Devices
    • Table 25 Leading Manufacturers/Suppliers of Hormonal Contraceptive Devices (Implants, Patches, Vaginal Rings, Iuds)
    • Hormonal Injectable Contraceptives
    • Table 26 Leading Manufacturers/Suppliers of Hormonal Injectable Contraceptive Devices
    • Condoms
    • Table 27 Leading Manufacturers/Suppliers of Condoms
    • Cervical Caps/ Diaphragms and Iuds (Non Hormonal Devices)
    • Table 28 Leading Manufacturers/Suppliers of Cervical Caps/ Diaphragms and Iuds
    • Spermicidal Agents
    • Table 29 Leading Manufacturers/Suppliers of Spermicidal Agents
    • Others (Transcervical Sterilization)
    • Table 30 Leading Manufacturers of Transcervical Sterilization Systems
    • Market Shares of Industry Leaders
    • Hormonal Oral Contraceptives
    • Table 31 Worldwide Market Shares of Manufacturers/Suppliers of Hormonal Oral Contraceptives, 2009 (%)
    • Figure 2 Worldwide Market Shares of Manufacturers/Suppliers of Hormonal Oral Contraceptives, 2009 (%)
    • Hormonal Contraceptive Devices
    • Table 32 Worldwide Market Shares of Manufacturers/Suppliers of Hormonal Contraceptive Devices, 2009 (%)
    • Figure 3 Worldwide Market Shares of Manufacturers/Suppliers of Hormonal Contraceptive Devices, 2009 (%)
    • Hormonal Injectable Contraceptives
    • Table 33 Worldwide Market Shares of Manufacturers/Suppliers of Hormonal Injectable Contraceptives, 2009 (%)
    • Figure 4 Worldwide Market Shares of Manufacturers/Suppliers of Hormonal Injectable Contraceptives, 2009 (%)
    • Condoms
    • Table 34 Worldwide Market Shares of Manufacturers/Suppliers of Condoms, 2009 (%)
    • Figure 5 Worldwide Market Shares of Manufacturers/Suppliers of Condoms, 2009 (%)
    • Cervical Caps/ Diaphragms and Iuds (Non Hormonal Devices)
    • Table 35 Worldwide Market Shares of Manufacturers/Suppliers of Cervical Caps/ Diaphragms and Iuds, 2009 (%)
    • Figure 6 Worldwide Market Shares of Manufacturers/Suppliers of Cervical Caps/ Diaphragms and Iuds, 2009 (%)
    • Spermicidal Agents
    • Table 36 Worldwide Market Shares of Manufacturers/Suppliers of Spermicidal Agents, 2009 (%)
    • Figure 7 Worldwide Market Shares of Manufacturers/Suppliers of Spermicidal Agents, 2009 (%)
    • Others (Transcervical Sterilization)
    • Table 37 Worldwide Market Shares of Manufacturers of Transcervical Sterilization, 2009 (%)
    • Figure 8 Worldwide Market Shares of Manufacturers Transcervical Sterilization, 2009 (%) 57
  • Chapter-7: New Developments
    • New Contraceptive Choices
    • Key Developments
    • Table 38 Key Developments Available or Soon to Be Available in Various Countries
    • Recent Advances in Oral and Transdermal Contraception
    • Table 39 Recent Advances in Oral and Transdermal Contraception
    • Recent Advances in Male Contraception
    • Table 40 Recent Advances in Male Contraception
    • New Entities in Contraception
    • Oral Contraceptives
    • Table 41 New Developments in Hormonal Contraceptives - Oral Contraceptives
    • Contraceptive Devices
    • Table 42 New Developments in Hormonal Contraceptive Devices - Implants, Patch, Vaginal Ring, Intra Uterine Device (Iud)
    • Recent Updates/ New Developments in The Contraceptive World
    • Watson Pharmaceuticals, Inc
    • Bayer Schering Pharma
    • Hra Pharma
    • Schering - Plough
    • Schering - Plough (Continued)
  • Chapter-8: Market Analysis
    • Hormonal Contraceptives
    • Table 43 Global Market for Hormonal Contraceptives through 2015 ($ Millions)
    • Figure 9 Worldwide Market for Hormonal Contraceptives 2008-2015 ($ Millions)
    • Oral Contraceptives
    • Market Overview
    • Market Overview (Continued)
    • Market Overview (Continued)
    • Market Revenue
    • Table 44 Worldwide Market for Oral Contraceptives by Region through 2015 ($ Millions)
    • Figure 10 Worldwide Market for Oral Contraceptives by Region 2008-2015 ($ Millions)
    • Hormonal Devices
    • Market Overview
    • Market Revenue
    • Table 45 Worldwide Market for Hormonal Devices Used as Contraceptives by Region, through 2015 ($ Millions)
    • Figure 11 Worldwide Market for Hormonal Devices Used as Contraceptives by Region, 2008-2015 ($ Millions)
    • Injectable Contraceptives
    • Market Overview
    • Market Revenue
    • Table 46 Worldwide Market for Hormonal Injectable Contraceptives by Region, through 2015 ($ Millions)
    • Figure 12 Worldwide Market for Hormonal Injectable Contraceptives by Region, 2008-2015 ($ Millions)
    • Market Shares of Hormonal Contraceptive Market, by Region
    • Table 47 Worldwide Hormonal Contraceptives Market Shares by Region, 2009 (%)
    • Figure 13 Worldwide Hormonal Contraceptive Market Shares by Region, 2009 (%)
    • Barrier Contraceptives
    • Table 48 Worldwide Market for Barrier Contraceptives, through 2015 ($ Millions)
    • Figure 14 Worldwide Market for Barrier Contraceptives 2008-2015 ($ Millions)
    • Market Overview
    • Market Revenue
    • Table 49 Worldwide Market for Condoms by Region through 2015 ($ Millions)
    • Figure 15 Worldwide Market for Condoms by Region 2008-2015 ($ Millions)
    • Cervical Cap/ Diaphragm and Iud (Non Hormonal Devices)
    • Market Overview
    • Market Revenue
    • Table 50 Worldwide Market for Cervical Caps/ Diaphragms and Iuds by Region, through 2015 ($ Millions)
    • Figure 16 Worldwide Market for Cervical Caps/Diaphragms and Iuds by Region, 2008-2015 ($ Millions)
    • Spermicidal Agents
    • Market Overview
    • Market Revenue
    • Table 51 Worldwide Market for Spermicidal Agents by Region, through 2015 ($ Millions)
    • Figure 17 Worldwide Market for Spermicidal Agents by Region 2008-2015 ($ Millions)
    • Market Shares of Barrier Contraceptive Market, by Region
    • Table 52 Worldwide Barrier Contraceptives Market Shares by Region, 2009 (%)
    • Figure 18 Worldwide Barrier Contraceptive Market Shares by Region, 2009 (%)
    • Other Contraceptives and Techniques
    • Market Overview
    • Market Revenue
    • Table 53 Worldwide Market for Transcervical Sterilization by Region, through 2015 ($ Millions)
    • Figure 19 Worldwide Market for Transcervical Sterilization by Region, 2008-2015 ($ Millions)
    • Market Shares of Contraceptive Market
    • Table 54 Contraceptives Market Shares, 2009 (%)
    • Figure 20 Contraceptives Market Shares, 2009 (%)
    • Market Shares of Contraceptive Market, by Region
    • Table 55 Worldwide Contraceptives Market Shares by Region, 2009 (%)
    • Figure 21 Worldwide Contraceptives Market Shares by Region, 2009 (%) 91
  • Chapter-9: Patent Analysis
    • Patents by Year
    • Table 56 Number of Significant Patents by Year, 2006 through 2010*
    • Figure 22 Number of Patents by Year, 2006-2010*
    • Figure 23 Percentage of Patents by Year, 2006-2010*
    • Patents by Technology
    • Table 57 Number of Patents by Technology, 2006-2010*
    • Figure 24 Number of Patents by Technology, 2006-2010*
    • Patents by Type
    • Hormonal Contraceptives
    • Table 58 Patents for Hormonal Contraceptive Types, 2006-2010*
    • Figure 25 Patents for Hormonal Contraceptive Types, 2006-2010*
    • Barrier Contraceptives
    • Table 59 Patents for Barrier Contraceptive Types, 2006-2010*
    • Figure 26 Patents for Barrier Contraceptive Types, 2006-2010*
    • Others
    • Table 60 Patents for Others Category, 2006 through 2010*
    • Figure 27 Patents for Others Category, 2006-2010*
    • Patents by Company
    • Hormonal Contraceptives
    • Table 61 Number of U.S. Patents by Company for Hormonal Contraceptives, 2006-2010*
    • Figure 28 Number of U.S. Patents by Company for Hormonal Contraceptives, 2006-2010*
    • Barrier Contraceptives
    • Table 62 Number of U.S. Patents by Company for Barrier Contraceptives, 2006-2010*
    • Figure 29 Number of U.S. Patents by Company for Barrier Contraceptives, 2006-2010*
    • Other Contraceptives
    • Table 63 Number of U.S. Patents by Company for Other Contraceptives, 2006-2010*
    • Figure 30 Number of U.S. Patents by Company for Other Contraceptives, 2006-2010*
    • Patents by Country
    • Hormonal Contraceptives
    • Table 64 Number of U.S. Patents by Country for Hormonal Contraceptives, 2006-2010*
    • Figure 31 Number of U.S. Patents by Country for Hormonal Contraceptives, 2006-2010*
    • Table 65 Patent Shares by Country for Hormonal Contraceptives, 2006-2010* (%)
    • Figure 32 Patent Shares by Country for Hormonal Contraceptives, 2006-2010* (%)
    • Barrier Contraceptives
    • Table 66 Number of U.S. Patents by Country for Barrier Contraceptives, 2006-2010*
    • Figure 33 Number of U.S. Patents by Country for Barrier Contraceptives, 2006-2010*
    • Table 67 Patent Shares by Country for Barrier Contraceptives 2006-2010* (%)
    • Figure 34 Patent Shares by Country for Barrier Contraceptives 2006-2010* (%)
    • Other Contraceptives
    • Table 68 Number of U.S. Patents by Country for Other Contraceptives, 2006-2010*
    • Figure 35 Number of U.S. Patents by Country for Other Contraceptives, 2006-2010*
    • Table 69 Patent Shares by Country for Other Contraceptives 2006-2010* (%)
    • Figure 36 Patent Shares by Country for Other Contraceptives 2006-2010* (%)
    • Patents by Assignee
    • Hormonal Contraceptives
    • Table 70 Patents by Assignee for Hormonal Contraceptives 2006-2010*
    • Figure 37 Patents by Assginee for Hormonal Contraceptives 2006-2010*
    • Barrier Contraceptives
    • Table 71 Patents by Assignee for Barrier Contraceptives 2006-2010*
    • Figure 38 Patents by Assginee for Barrier Contraceptives 2006-2010*
    • Other Contraceptives
    • Table 72 Patents by Assignee for Other Contraceptives 2006-2010*
    • Figure 39 Patents by Assginee for Other Contraceptives 2006-2010* 112
  • Chapter-10: Market Trends
    • Summary of Demand and Production of Contraceptives
    • Social Influences on Contraception Market
    • Economic Trend' S Influence on Contraception
    • Factors Affecting The Sales of Contraceptives
    • Increasing Awareness
    • Competition
    • Cost of The Drugs
    • Patents Expirations
    • Innovation
    • Direct - to - Consumer Advertising
    • Women at Risk
    • Prevention of Teenage Preganancy and Stis
    • Use of Condoms
    • Use of Emergency Contraceptive Pills
    • Barriers in Ecp Access
    • Role of The Healthcare Provider in Enhancing Adolescents' Awareness and Use of Ecps
    • Public Health Campaigns 121
  • Chapter-11: Company Profiles
    • Agile Therapeutics
    • Ansell Healthcare, Inc
    • Ansell Limited
    • Apothecus Pharmaceuticals Corporation
    • Bayer Health Care/Bayer Schering Pharma Ag, Germany
    • Bravo Condoms
    • Caution Wear Corp
    • Church & Dwight Co., Inc
    • Conceptus, Inc
    • Condax Medical Products, Llc
    • Dkt International
    • Durbin Plc
    • Femcap, Inc
    • Global Protection Corp
    • Hologic Inc
    • Hra Pharma
    • Janssen - Cilag - Pharma (A Johnson & Johnson Company)
    • Marlborough Pharmaceuticals Ltd
    • Mayer Laboratories, Inc
    • Medtech Products Limited
    • Merck & Co., Inc
    • Okamoto U.S.A., Inc
    • Ortho - Mcneil - Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Company)
    • Pfizer Inc
    • Revive Personal Products Co
    • Ssl International, Plc
    • Stragen Pharma
    • Teva Pharmaceutical Industries Ltd
    • The Female Health Company (Fch)
    • Veos, Plc
    • Warner Chilcott
    • Watson Pharmaceuticals, Inc
    • Williams Medical Supplies (Wms)
    • Yama ,Inc.
    • Appendix
    • Appendix I - Abbreviations
    • Abbreviations
+44 20 8816 8548

Ask a question about Contraceptives

Enter the characters you see in the picture below
Captcha